Research and Markets: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8gkhq8/chronic) has announced the addition of the "Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Lymphocytic Leukemia (CLL) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chronic Lymphocytic Leukemia (CLL) Overview
  3. Therapeutics Development
  4. Chronic Lymphocytic Leukemia (CLL) - Therapeutics under Development by Companies
  5. Chronic Lymphocytic Leukemia (CLL) - Therapeutics under Investigation by Universities/Institutes
  6. Chronic Lymphocytic Leukemia (CLL) - Pipeline Products Glance
  7. Chronic Lymphocytic Leukemia (CLL) - Products under Development by Companies
  8. Chronic Lymphocytic Leukemia (CLL) - Products under Investigation by Universities/Institutes
  9. Chronic Lymphocytic Leukemia (CLL) - Companies Involved in Therapeutics Development
  10. Chronic Lymphocytic Leukemia (CLL) - Therapeutics Assessment
  11. Chronic Lymphocytic Leukemia (CLL) - Recent Pipeline Updates
  12. Chronic Lymphocytic Leukemia (CLL) - Dormant Projects
  13. Chronic Lymphocytic Leukemia (CLL) - Discontinued Products
  14. Chronic Lymphocytic Leukemia (CLL) - Product Development Milestones
  15. Appendix

For more information visit http://www.researchandmarkets.com/research/8gkhq8/chronic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology